Niche Interim Sequoia Research provides interim management services for pharmaceutical and biotechnology companies, creating opportunities to sell specialized advisory and execution support such as business development, licensing, project management, and due diligence to firms seeking flexible leadership and rapid deal execution.

Deal Scouting Their core offerings include technology scouting, technology evaluation, patent position assessment, and vendor/CRO evaluation, indicating potential sales opportunities around strategic partnerships, acquisition targeting, and contract optimization for clients pursuing external innovation and outsourcing efficiency.

Limited Scale With a reported revenue under $1M and an extremely lean headcount, there is a clear need for scalable, affordable consulting engagements and retainer-based services that can grow with client portfolios without committing to full-time hires.

Market Readiness Operating in pharmaceuticals and biotech, Sequoia can be positioned as a nimble, early-stage partner for due diligence, market assessments, and competitive benchmarking—services that enhance deal flow and reduce time-to-close for potential clients in competitive pipelines.

Competitive Context Similar firms include large research and consulting organizations; this suggests an opportunity to differentiate with targeted, boutique offerings, scalable engagements, and rapid turnaround for core activities like licensing negotiations, vendor evaluation, and strategic technology scouting.